Multimedia Neuroscience Learning (MNL)
We have developed a few online, multimedia learning opportunities for you to maintain and develop your knowledge and understanding of recent advances in clinically relevant, cutting-edge neuroscience.
Each module includes a fully-referenced Introduction to the topic, Intended Learning Outcomes, all of the slides from the speaker’s presentation, a Summary and a short Assessment of Learning; to take your learning even further, we have added some recommended Extension Activities.
Expand the sections below and then click on a relevant link to open the PDF presentation for the topic you are interested in (it will open in a new window), then click the associated link to open the corresponding film of the presentation.
Completing one of our Multimedia Neuroscience Learning modules entitles you to 1 Credit for CPD, subject to peer approval.
Dr Ivan Koychev shows us how important biomarkers are to support diagnosis and monitor the progression of Alzheimer’s Disease. Ivan describes biomarkers that are currently in use for cognition, neurodegeneration, amyloid and tau. He then tells us about biomarkers for these four that might become available in the near and more distant future.
Ivan also highlights the potential for clinical application of selected experimental biomarkers, including measures of Activities of Daily Living (ADLs), sleep, and synaptic function.
Access the presentation slides (PDF) (together with an introduction to the topic, learning objectives, presentation summary and self-evaluation)
Dr David Okai tells us how research in neuroscience is crossing over into the clinic to help improve the lives of people with movement disorders such as Parkinson’s Disease. David focuses on the causation, measurement and treatment of impulse-control behaviours.
Access the presentation slides (PDF) (together with an introduction to the topic, learning objectives, presentation summary and self-evaluation)
Modern imaging techniques are revealing much more of the fine detail of brain composition and of how the brain works in health and disease.
The most recent developments provide precise, quantitative information about clinically-relevant aspects of brain structure, such as changes in white matter volume in Alzheimer's disease.
Meanwhile, functional imaging can generate data relating to a range of parameters, including:
- activity in different areas of the brain during a range of activities
- temporal changes in brain chemistry, such as neurotransmitter receptor occupancy
- the production of metabolites
Dr Matt Wall summarises the historical development of methods for visualising the living brain. He explains the basic principles and selected applications of positron emission tomography (PET) and magnetic resonance imaging (MRI).
Matt also shows us how by combining the data obtained using complementary methods, it is becoming possible to see areas of psychiatric diagnosis and treatment for which brain imaging offers real value in improving patient care.
Professor Emily Jones talks about her research into brain activity during social interactions in children and young people. Emily is evaluating measurement techniques to support a precision medicine approach to Autism Spectrum Disorder (ASD). These include electroencephalography (EEG) and functional magnetic resonance imaging (fMRI).
Emily hopes to identify brain-based biomarkers to investigate adaptive social functioning in ASD. Ultimately, this could improve clinical practice by enabling patient stratification and better matching of treatments to patients.
